GSK Promises 'Greater Transparency' From Consumer Brand Reshuffle
In the wake of its joint venture with Pfizer, GSK Consumer Healthcare has shaken up how it reports its sales by category to highlight the "main drivers" of performance.
You may also be interested in...
Deal with Foundation Consumer Brands marks GSK’s latest sale of OTC and nutritional brands that aren’t strong enough revenue drivers to remain part of its consumer health JV with Pfizer. GSK has controlled the brands it’s divesting for less than a year.
While some parts of the world stocked up on OTC drugs, others went into total lock down, resulting in a mixed picture for GSK's Consumer Healthcare performance in Q1.
GSK commits to investing behind OTC and oral health brands in India after offloading nutrition assets to Unilever.